W

Wenfeng Fang

Sun Yat-sen University

ORCID: 0000-0002-6440-8246

Publishes on Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies. 420 papers and 10.1k citations.

PubIndex Score98Top 2% · mid-careerHow it's scored

420Publications

10.1kTotal Citations

First publication: 1982First senior author: 2019

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies HER2/EGFR in Cancer Research Lung Cancer Diagnosis and Treatment

Top publicationsby citations

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

Wenfeng Fang, Li Zhang|Oncotarget|2014

Cited by 386

PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival

Wenfeng Fang, Li Zhang|Oncotarget|2015

Cited by 93

EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47

Liyang Hu, Wenfeng Fang|Journal of Thoracic Oncology|2024

Cited by 46

Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer

Wenfeng Fang, Li Zhang|Journal of Cancer|2017

Cited by 34

Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer

Shen Zhao, Wenfeng Fang|Nature Communications|2023

Cited by 16